Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial

OBJECTIVE: As artificial pancreas (AP) becomes standard of care, consideration of extended use of insulin infusion sets (IIS) and continuous glucose monitors (CGMs) becomes vital. We conducted an outpatient randomized crossover study to test the safety and efficacy of a zone model predictive control...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetes Care
Päätekijät: Forlenza, Gregory P., Deshpande, Sunil, Ly, Trang T., Howsmon, Daniel P., Cameron, Faye, Baysal, Nihat, Mauritzen, Eric, Marcal, Tatiana, Towers, Lindsey, Bequette, B. Wayne, Huyett, Lauren M., Pinsker, Jordan E., Gondhalekar, Ravi, Doyle, Francis J., Maahs, David M., Buckingham, Bruce A., Dassau, Eyal
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Diabetes Association 2017
Aiheet:
Emerging Technologies and Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5521973/
https://ncbi.nlm.nih.gov/pubmed/28584075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc17-0500
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia